Bruker (MEX:BRKR) Cyclically Adjusted Revenue per Share: MXN223.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BRKR Bruker Corp MEX:BRKR
86 GF Score
Price MXN705.00
GF Value MXN795.90
! 7 Warning Signs
View Full Analysis

What is Bruker Cyclically Adjusted Revenue per Share?

Bruker MEX:BRKR 86 Cyclically Adjusted Revenue per Share is MXN223.99 as of Jun. 2026. GuruFocus rates MEX:BRKR with a GF Score™ of 86/100 and a GF Value™ of MXN795.90. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bruker's adjusted revenue per share for the three months ended in Jun. 2026 was MXN96.067. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN223.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bruker's average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bruker was 14.10% per year. The lowest was 5.90% per year. And the median was 8.00% per year.

As of today (2026-09-13), Bruker's current stock price is MXN705.00. Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN223.99. Bruker's Cyclically Adjusted PS Ratio of today is 3.15.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bruker was 7.22. The lowest was 1.74. And the median was 3.64.


Bruker  (MEX:BRKR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bruker's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=705.00/223.99
=3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bruker was 7.22. The lowest was 1.74. And the median was 3.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bruker Cyclically Adjusted Revenue per Share Related Terms


Bruker Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bruker's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Cyclically Adjusted Revenue per Share Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 261.06 288.33 287.99 356.04 271.02

Bruker Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 340.39 338.83 271.02 364.60 223.99

MEX:BRKR vs PODD, BIO, GKOS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PS Ratio falls into.


MEX:BRKR
86GF Score
Bruker Corp MEX:BRKR
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bruker's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=96.067/333.9520*333.9520
=96.067

Current CPI (Jun. 2026) = 333.9520.

Bruker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 47.159 241.428 65.232
201612 60.337 241.432 83.459
201703 45.154 243.801 61.851
201706 46.756 244.955 63.743
201709 49.813 246.819 67.398
201712 66.489 246.524 90.069
201803 49.955 249.554 66.850
201806 55.532 251.989 73.595
201809 55.450 252.439 73.355
201812 69.147 251.233 91.914
201903 56.683 254.202 74.466
201906 59.747 256.143 77.896
201909 66.115 256.759 85.992
201912 72.806 256.974 94.615
202003 63.977 258.115 82.774
202006 63.353 257.797 82.068
202009 73.217 260.280 93.941
202012 81.053 260.474 103.918
202103 74.012 264.877 93.313
202106 74.312 271.696 91.340
202109 81.938 274.310 99.753
202112 91.883 278.802 110.058
202203 78.250 287.504 90.892
202206 79.022 296.311 89.060
202209 86.484 296.808 97.307
202212 93.380 296.797 105.070
202303 83.689 301.836 92.594
202306 79.150 305.109 86.632
202309 87.839 307.789 95.306
202312 99.142 306.746 107.935
202403 82.094 312.332 87.777
202406 99.114 314.175 105.353
202409 111.976 315.301 118.600
202412 134.498 315.605 142.317
202503 107.934 319.799 112.711
202506 98.974 322.561 102.469
202509 103.987 324.800 106.917
202512 115.682 324.054 119.215
202603 97.237 330.213 98.338
202606 96.067 333.952 96.067

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN223.99 mean?
Bruker (MEX:BRKR) has a Cyclically Adjusted Revenue per Share of MXN223.99 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bruker and its competitors.
Is Bruker's Cyclically Adjusted Revenue per Share too high?
Bruker's current Cyclically Adjusted Revenue per Share is MXN223.99. Overall, Bruker has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Bruker's Cyclically Adjusted Revenue per Share compare to PODD and BIO?
Bruker's Cyclically Adjusted Revenue per Share of MXN223.99 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bruker and its competitors. Bruker's current Cyclically Adjusted Revenue per Share is MXN223.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Bruker (MEX:BRKR) has a current Cyclically Adjusted Revenue per Share of MXN223.99. The stock's GF Value™ is MXN795.90, compared to a current price of MXN705.00 — trading 11.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN223.99. Bruker's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bruker (MEX:BRKR), the current Cyclically Adjusted Revenue per Share is MXN223.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (MEX:BRKR) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of MXN705.00 is trading 11.4% below its estimated GF Value™ of MXN795.90.

Key valuation signals for MEX:BRKR:

  • Cyclically Adjusted Revenue per Share: MXN223.99
  • GF Value™: MXN795.90 vs. price of MXN705.00 (11.4% below fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the MEX:BRKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for MEX:BRKR

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN705.00
Price
MXN795.90
GF Value